drugset / Trial / NCT02464176

Systemic Steroids for Peripheral Nerve Blocks

NCT02464176 ↗

Phase 4 Completed 115 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will investigate the ability of systemic dexamethasone to prolong the sensory block duration for lumbar plexus nerve blockade.

Timeline

Start
2015-06
Primary completion
2017-01
Completion
2017-01

Outcome

Missed primary endpoint

paper However, neither group differed from placebo [19.6 h (6.7), (4 mg vs placebo), P=0.97; (8 mg vs placebo), P=0.77)]. PMID 29406180 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 4 mg Intravenous
Subject Dexamethasone Small molecule 8 mg Intravenous
Background Bupivacaine Other / unclassified 0.25 % Other
Background Epinephrine Other / unclassified — Other

Indications